Timothy Tyson Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Timothy Tyson is of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 33,189 shares of SYRS, which is worth approximately $70,692. The most recent transaction as insider was on Jun 05, 2024, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.2K
0% 3M change
13.7% 12M change
Total Value Held $70,692

TIMOTHY TYSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 10.76%
33,189 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
4,000 Added 12.05%
29,189 Common Stock
Sep 30 2022
BUY
Open market or private purchase
$89,180 $6.37 p/Share
14,000 Added 35.96%
24,932 Common Stock
Sep 29 2022
BUY
Open market or private purchase
$16,771 $5.72 p/Share
2,932 Added 21.15%
10,932 Common Stock
Sep 16 2022
BUY
Grant, award, or other acquisition
-
8,000 Added 50.0%
8,000 Common Stock

Also insider at

TYME
TYME TECHNOLOGIES, INC.
Director
TT

Timothy Tyson

Bedminster, NJ

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS